Hartig Drug Company Inc. v. Senju Pharmaceutical Co. Ltd. et al
Plaintiff: Hartig Drug Company Inc.
Defendant: Allergan Inc., Kyorin Pharmaceutical Co. Ltd. and Senju Pharmaceutical Co. Ltd.
Case Number: 1:2014cv00719
Filed: June 6, 2014
Court: US District Court for the District of Delaware
Office: Wilmington Office
County: XX US, Outside State
Presiding Judge: Joseph F Bataillon
Referring Judge: Sherry R Fallon
Nature of Suit: Anti-Trust
Cause of Action: 15 U.S.C. § 1
Jury Demanded By: Plaintiff
Docket Report

This docket was last retrieved on August 7, 2019. A more recent docket listing may be available from PACER.

Date Filed Document Text
August 7, 2019 Opinion or Order Filing 80 ORDER - granting #77 Motion for Settlement. The Net Settlement Fund ($5,883,838.76) shall be distributed to Settlement Classmembers who have submitted valid claims, as determined by The Garden City Group, in the amounts shown on Exhibit A of the Declaration of Eric Kierkegaard, filed April 5, 2019. Signed by Judge Joseph F. Bataillon on 8/7/19. (rwc)
April 9, 2019 Motions No Longer Referred: #77 Unopposed Motion to Authorize Distributions of the Settlement Fund. Counsel is advised not to forward courtesy copies of the motion and related documents to Judge Fallon's chambers. (lih)
April 8, 2019 Filing 79 Supplemental DECLARATION of Eric Kierkegaard re #77 Motion to Authorize Distributions of the Settlement Fund, #78 MEMORANDUM in Support by Hartig Drug Company Inc.. (Attachments: #1 Exhibit A)(Athey, J.) Modified on 4/9/2019 (lih).
April 8, 2019 Filing 78 MEMORANDUM in Support re #77 Motion to Authorize Distributions of the Settlement Fund filed by Hartig Drug Company Inc..Answering Brief/Response due date per Local Rules is 4/22/2019. (Athey, J.) Modified on 4/9/2019 (lih).
April 8, 2019 Filing 77 Unopposed Motion to Authorize Distributions of the Settlement Fund - filed by Hartig Drug Company Inc.. (Attachments: #1 Text of Proposed Order).(Athey, J.) Modified on 4/9/2019 (lih).
November 13, 2018 Filing 76 JUDGMENT (CASE CLOSED). Signed by Judge Joseph F. Bataillon on 11/9/2018. (nmg)
November 13, 2018 Opinion or Order Filing 75 ORDER approving D.I. #71 Unopposed Motion for Final Approval of Proposed Settlement. Signed by Judge Joseph F. Bataillon on 11/9/2018. (nmg)
November 9, 2018 Minute Entry for proceedings held before Judge Joseph F. Bataillon - Final Fairness Hearing held on 11/9/2018. (Court Reporter: Valerie Gunning.) (ceg)
October 26, 2018 Filing 74 DECLARATION of Eric Kierkegaard re #71 Unopposed Motion for Final Approval of Proposed Settlement, #72 MEMORANDUM in Support by Hartig Drug Company Inc.. (Attachments: #1 Exhibit Exhibit A-B)(Athey, J.) Modified on 10/29/2018 (lih).
October 26, 2018 Filing 73 DECLARATION of Rosanna K. McCalips re #71 Unopposed Motion for Final Approval of Proposed Settlement, #72 MEMORANDUM in Support by Hartig Drug Company Inc.. (Attachments: #1 Exhibit Exhibit 1)(Athey, J.) Modified on 10/29/2018 (lih).
October 26, 2018 Filing 72 MEMORANDUM in Support re #71 Unopposed Motion for Final Approval of Proposed Settlement filed by Hartig Drug Company Inc..Answering Brief/Response due date per Local Rules is 11/9/2018. (Athey, J.) Modified on 10/29/2018 (lih).
October 26, 2018 Filing 71 Unopposed Motion for Final Approval of Proposed Settlement - filed by Hartig Drug Company Inc.. (Attachments: #1 Text of Proposed Order) .(Athey, J.) Modified on 10/29/2018 (lih).
October 16, 2018 Opinion or Order Filing 70 ORDER granting D.I. #64 Unopposed MOTION for Attorney Fees and Incentive Award (See Order for Further Details). Signed by Judge Joseph F. Bataillon on 10/15/2018. (nmg)
September 26, 2018 Motions No Longer Referred: #64 MOTION for Attorney Fees. (lih)
September 25, 2018 Filing 69 DECLARATION of Gregory A. Frank re #64 Unopposed MOTION for Attorney Fees and Incentive Award by Hartig Drug Company Inc.. (Athey, J.) Modified on 9/26/2018 (lih).
September 25, 2018 Filing 68 DECLARATION of Melinda R. Coolidge re #64 Unopposed MOTION for Attorney Fees and Incentive Award by Hartig Drug Company Inc.. (Athey, J.) Modified on 9/26/2018 (lih).
September 25, 2018 Filing 67 DECLARATION of J. Clayton Athey re #64 Unopposed MOTION for Attorney Fees and Incentive Award by Hartig Drug Company Inc.. (Athey, J.) Modified on 9/26/2018 (lih).
September 25, 2018 Filing 66 Joint DECLARATION re #64 Unopposed MOTION for Attorney Fees and Incentive Award by Hartig Drug Company Inc.. (Athey, J.) Modified on 9/26/2018 (lih).
September 25, 2018 Filing 65 MEMORANDUM in Support re #64 Unopposed MOTION for Attorney Fees and Incentive Award filed by Hartig Drug Company Inc..Answering Brief/Response due date per Local Rules is 10/9/2018. (Athey, J.) Modified on 9/26/2018 (lih).
September 25, 2018 Filing 64 Unopposed MOTION for Attorney Fees and Incentive Award - filed by Hartig Drug Company Inc.. (Attachments: #1 Text of Proposed Order )(Athey, J.) Modified on 9/26/2018 (lih). Modified on 9/26/2018 (lih).
May 10, 2018 Opinion or Order Filing 63 ORDER approving #62 STIPULATION and Proposed Order Regarding Notice and Claims Deadlines re #56 Order on Motion for Settlement, #61 Order. Signed by Judge Joseph F. Bataillon on 5/10/2018. (nmf)
May 9, 2018 Filing 62 STIPULATION and Proposed Order Regarding Notice and Claims Deadlines re #56 Order on Motion for Settlement, #61 Order by Hartig Drug Company Inc.. (Athey, J.) Modified on 5/9/2018 (lih).
May 3, 2018 Opinion or Order Filing 61 ORDER granting #58 MOTION to Distribute Notice to the Settlement Class and for Approval of the Plan of Allocation. A Final Fairness Hearing is set for 11/9/2018 at 01:30 PM in Courtroom 4B before Judge Joseph F. Bataillon. (See Order for further details). Signed by Judge Joseph F. Bataillon on 5/3/2018. (crb)
May 1, 2018 Motions No Longer Referred: #58 MOTION for Settlement. (lih)
April 30, 2018 Filing 60 DECLARATION of Brandon Schwartz re #59 MEMORANDUM in Support by Hartig Drug Company Inc.. (Attachments: #1 Exhibits A-C)(Athey, J.) Modified on 5/1/2018 (lih).
April 30, 2018 Filing 59 MEMORANDUM in Support re #58 Unopposed Motion to Distribute Notice to the Settlement Class and for Approval of the Plan of Allocation filed by Hartig Drug Company Inc..Answering Brief/Response due date per Local Rules is 5/14/2018. (Athey, J.) Modified on 5/1/2018 (lih).
April 30, 2018 Filing 58 Unopposed MOTION to Distribute Notice to the Settlement Class and for Approval of the Plan of Allocation - filed by Hartig Drug Company Inc.. (Attachments: #1 Text of Proposed Order)Motions referred to Sherry R. Fallon.(Athey, J.) Modified on 5/1/2018 (lih).
March 30, 2018 Filing 57 NOTICE of Withdrawal of Counsel of Benjamin J. Schladweiler by Kyorin Pharmaceutical Co. Ltd. (Schladweiler, Benjamin)
February 27, 2018 Opinion or Order Filing 56 ORDER granting #53 Plaintiff's Unopposed Motion for Preliminary Approval of Class Settlement. The parties shall notify the court sixty (60) days from the date of this order, as to when the fairness hearing should take place. Signed by Judge Joseph F. Bataillon on 2/27/18. (gvw)
February 27, 2018 Opinion or Order ORAL ORDER- IT IS HEREBY ORDERED that: the status teleconference set in this matter for 3/5/2018 is CANCELLED. IT IS FURTHER ORDERED that: the requirement to submit a joint status report on or before 3/2/2018 is VACATED. Ordered by Judge Sherry R. Fallon on 2/27/2018. (lih)
February 16, 2018 Filing 55 DECLARATION of Melinda R. Coolidge re #53 MOTION for Preliminary Approval of Proposed Settlement, #54 MEMORANDUM in Support by Hartig Drug Company Inc.. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4, #5 Exhibit 5)(Athey, J.) Modified on 2/16/2018 (lih).
February 16, 2018 Filing 54 MEMORANDUM in Support re #53 MOTION for Preliminary Approval of Proposed Settlement filed by Hartig Drug Company Inc..Answering Brief/Response due date per Local Rules is 3/2/2018. (Athey, J.) Modified on 2/16/2018 (lih).
February 16, 2018 Filing 53 Unopposed MOTION for Preliminary Approval of Proposed Settlement - filed by Hartig Drug Company Inc.. (Attachments: #1 Text of Proposed Order)Motions referred to Sherry R. Fallon.(Athey, J.) Modified on 2/16/2018 (lih).
February 16, 2018 Motions No Longer Referred: #53 MOTION for Settlement (lih)
January 30, 2018 Opinion or Order ORAL ORDER- re #52 Status Report. Counsel shall file a supplemental joint status report by no later than noon on 3/2/2018. IT IS FURTHER ORDERED that: the status teleconference set in this matter for 1/31/2018 is RESCHEDULED to 3/5/2018 at 11:00 AM before Judge Sherry R. Fallon. Counsel for the plaintiff shall initiate the call to 302-573-4557. Ordered by Judge Sherry R. Fallon on 1/30/2018. (lih)
January 26, 2018 Filing 52 Joint Supplemental Status Report by Kyorin Pharmaceutical Co. Ltd.. (Schladweiler, Benjamin) Modified on 1/29/2018 (lih).
December 27, 2017 Filing 51 NOTICE requesting Clerk to remove Kevin D. McDonald, Esquire as co-counsel. Reason for request: no longer with the firm of Jones Day. (Schladweiler, Benjamin)
November 29, 2017 Opinion or Order ORAL ORDER- re #50 Status Report. Counsel shall file a supplemental joint status report on or before 1/26/2018. IT IS FURTHER ORDERED that: the status teleconference set in this matter for 12/4/2017 is RESCHEDULED to 1/31/2018 at 11:00 AM before Judge Sherry R. Fallon. Counsel for the plaintiff shall initiate the call to 302-573-4557. Ordered by Judge Sherry R. Fallon on 11/29/2017. (lih)
November 27, 2017 Filing 50 Joint STATUS REPORT by Kyorin Pharmaceutical Co. Ltd.. (Schladweiler, Benjamin)
September 12, 2017 Pro Hac Vice Attorney John M. Majoras,Kevin D. McDonald for Kyorin Pharmaceutical Co. Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (crb)
September 5, 2017 Opinion or Order SO ORDERED- re #48 Stipulation, #49 Stipulation. Signed by Judge Sherry R. Fallon on 9/1/2017. (lih)
August 31, 2017 Filing 49 STIPULATION Regarding Third-Party Documents produced by non-party Actavis, Inc. by Hartig Drug Company Inc.. (Juray, Eric) Modified on 9/1/2017 (lih).
August 31, 2017 Filing 48 STIPULATION Regarding Third-Party Documents produced by non-party Akorn, Inc. by Hartig Drug Company Inc.. (Juray, Eric) Modified on 9/1/2017 (lih).
August 23, 2017 Opinion or Order SO ORDERED- re #43 Stipulation and Proposed Order Regarding Third-Party Documents. Signed by Judge Sherry R. Fallon on 8/23/2017. (lih)
August 23, 2017 Opinion or Order ORAL ORDER- re #47 Status Report. IT IS HEREBY ORDERED that: counsel shall submit a joint status report and proposed case schedule on or before 11/27/2017. IT IS FURTHER ORDERED that: the court shall conduct a status teleconference on 12/4/2017 at 11:00 AM before Judge Sherry R. Fallon. Counsel for the plaintiff shall initiate the call to 302-573-4557. Ordered by Judge Sherry R. Fallon on 8/23/2017. (lih)
August 22, 2017 Filing 47 Joint STATUS REPORT by Hartig Drug Company Inc.. (Juray, Eric) Modified on 8/22/2017 (lih).
August 9, 2017 Filing 46 CASE REFERRED to Magistrate Judge Sherry R. Fallon. (Lawrence, Tiwauna)
August 9, 2017 Opinion or Order Filing 45 ORAL ORDER - Pursuant to the filing of this case, the Court issues the following order: This case shall be immediately referred to Magistrate Judge Sherry R. Fallon. Magistrate Judge Fallon shall issue a scheduling order when appropriate. Magistrate Judge Fallon shall handle all dispositive and nondispositive matters on all issues, except for summary judgments, Daubert motions and pretrial motions in limine. On all dispositive matters, the magistrate judge shall issue a report and recommendation. The parties have the right to file objections to the report and recommendation, or in the case of nondispositive matters, file an appeal of the magistrate judge's order, and the same shall be decided by the undersigned. The magistrate judge shall likewise handle all discovery matters, scheduling, and pretrial conferences. If the parties believe the magistrate judge has a conflict of interest with this case, the parties shall so notify the Court. IT IS SO ORDERED. Signed by Judge Joseph F. Bataillon on 8/9/2017. (Lawrence, Tiwauna)
August 3, 2017 Filing 44 NOTICE requesting Clerk to remove Sara R. Kusiak, Esquire as co-counsel. Reason for request: no longer with the law firm of Jones Day. (Schladweiler, Benjamin)
August 2, 2017 Filing 43 STIPULATION Stipulation and Proposed Order Regarding Third-Party Documents by Hartig Drug Company Inc.. (Juray, Eric)
August 1, 2017 Case Reassigned to Judge Joseph F. Bataillon of the District of Nebraska (in lieu of Vacant Judgeship). Please include the initials of the Judge (JFB) after the case number on all documents filed. (rjb)
June 28, 2017 Filing 42 Joint STATUS REPORT by Allergan Inc.. (Tigan, Jeremy)
February 23, 2017 Opinion or Order SO ORDERED, re #41 Stipulation and Agreed Upon Order Regarding Third-Party Documents filed by Kyorin Pharmaceutical Co. Ltd. Signed by Judge Sue L. Robinson on 2/23/2017. (fms)
February 22, 2017 Filing 41 Joint STIPULATION and Agreed Upon [Proposed] Order Regarding Third-Party Documents by Kyorin Pharmaceutical Co. Ltd.. (Schladweiler, Benjamin)
November 9, 2016 Opinion or Order SO ORDERED, re #40 Stipulated Protective Order filed by Allergan Inc. Signed by Judge Sue L. Robinson on 11/9/2016. (fms)
November 8, 2016 Filing 40 PROPOSED ORDER // Protective Order by Allergan Inc.. (Tigan, Jeremy)
November 1, 2016 Opinion or Order SO ORDERED, re #39 Stipulation filed by Allergan Inc., Case stayed. Signed by Judge Sue L. Robinson on 11/1/2016. (fms)
October 31, 2016 Filing 39 Joint STIPULATION to Stay by Allergan Inc.. (Tigan, Jeremy)
October 19, 2016 Minute Entry for proceedings held before Judge Sue L. Robinson - Telephone Conference held on 10/19/2016. (Court Reporter V. Gunning.) (nmfn)
October 12, 2016 Opinion or Order Filing 38 ORDER Setting Teleconference: Counsel for plaintiff to initiate the call. A Telephone Conference is set for 10/19/2016 at 02:00 PM before Judge Sue L. Robinson. Signed by Judge Sue L. Robinson on 10/12/2016. (nmfn)
October 11, 2016 Filing 37 MANDATE of USCA as to #34 Notice of Appeal (Third Circuit) filed by Hartig Drug Company Inc. Vacated and Remanded. (Attachments: #1 Precedential _ Opinion)(dw2, ) Modified on 10/11/2016 (fms).
September 21, 2015 Filing 36 TRANSCRIPT REQUEST by Hartig Drug Company Inc. Transcript Not Needed (Athey, J.)
September 21, 2015 Filing 35 NOTICE of Docketing Record on Appeal from USCA for the Third Circuit re #34 Notice of Appeal (Third Circuit) filed by Hartig Drug Company Inc. USCA Case Number 15-3289. USCA Case Manager: Desiree (DOCUMENT IS RESTRICTED AND CAN ONLY BE VIEWED BY COURT STAFF) (kr)
September 18, 2015 Filing 34 NOTICE OF APPEAL of #33 Order on Motion to Dismiss/Lack of Subject Jurisdiction, Order on Motion to Dismiss/Failure to State Claim, #32 Memorandum Opinion . Appeal filed by Hartig Drug Company Inc.. (Athey, J.)
September 18, 2015 APPEAL - Credit Card Payment of $505.00 received re #34 Notice of Appeal (Third Circuit) filed by Hartig Drug Company Inc.. ( Filing fee $505, receipt number 0311-1789815.) (Athey, J.)
August 19, 2015 Opinion or Order Filing 33 ORDER granting #14 Motion to Dismiss for Lack of Subject Jurisdiction ; finding as moot #17 Motion to Dismiss (CASE CLOSED). Signed by Judge Sue L. Robinson on 8/19/2015. (nmfn)
August 19, 2015 Filing 32 MEMORANDUM OPINION. Signed by Judge Sue L. Robinson on 8/19/2015. (nmfn)
July 31, 2015 Filing 31 Letter to The Honorable Sue L. Robinson from Jack B. Blumenfeld regarding response to Hartig's letter - re #30 Letter,. (Blumenfeld, Jack)
July 23, 2015 Filing 30 Letter to The Honorable Sue L. Robinson from J. Clayton Athey regarding enclosing recent decision relevant to the pending motions to dimiss - re #14 MOTION to Dismiss for Lack of Jurisdiction Over the Subject Matter , #17 Joint MOTION to Dismiss for Failure to State a Claim / Defendants Kyorin Pharmaceutical Co. Ltd. and Senju Pharmaceutical Co. Ltd.'s Joint Motion to Dismiss. (Attachments: #1 Attachment to Letter to The Honorable Sue L. Robinson)(Athey, J.)
December 22, 2014 Filing 29 NOTICE of Withdrawal of Counsel by Allergan Inc. (Murphy, Regina)
November 20, 2014 Filing 28 REQUEST for Oral Argument by Kyorin Pharmaceutical Co. Ltd., Senju Pharmaceutical Co. Ltd. re #17 Joint MOTION to Dismiss for Failure to State a Claim / Defendants Kyorin Pharmaceutical Co. Ltd. and Senju Pharmaceutical Co. Ltd.'s Joint Motion to Dismiss. (Schladweiler, Benjamin)
November 20, 2014 Filing 27 Letter to The Honorable Sue L. Robinson from Jack B. Blumenfeld regarding Request for Oral Argument. (Blumenfeld, Jack)
November 13, 2014 Filing 26 Joint REPLY BRIEF re #17 Joint MOTION to Dismiss for Failure to State a Claim / Defendants Kyorin Pharmaceutical Co. Ltd. and Senju Pharmaceutical Co. Ltd.'s Joint Motion to Dismiss / Defendants Kyorin Pharmaceutical Co. Ltd. and Senju Pharmaceutical Co. Ltd.'s Reply Brief in Further Support of Their Joint Motion to Dismiss filed by Kyorin Pharmaceutical Co. Ltd., Senju Pharmaceutical Co. Ltd.. (Attachments: #1 Exhibit A)(Schladweiler, Benjamin)
November 13, 2014 Filing 25 REPLY BRIEF re #14 MOTION to Dismiss for Lack of Jurisdiction Over the Subject Matter filed by Allergan Inc.. (Murphy, Regina)
October 24, 2014 Filing 24 MOTION for Pro Hac Vice Appearance of Attorney Gerald W. Griffin - filed by Senju Pharmaceutical Co. Ltd.. (Attachments: #1 Certification of Gerald W. Griffin)(Brauerman, Stephen)
October 24, 2014 Opinion or Order SO ORDERED, re #24 MOTION for Pro Hac Vice Appearance of Attorney Gerald W. Griffin filed by Senju Pharmaceutical Co. Ltd. Signed by Judge Sue L. Robinson on 10/24/2014. (fms)
October 23, 2014 Pro Hac Vice Attorney Derrick Takeuchi for Senju Pharmaceutical Co. Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mas)
October 23, 2014 Pro Hac Vice Attorney William F. Sondericker for Senju Pharmaceutical Co. Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (dmp, )
October 21, 2014 CORRECTING ENTRY: D.I. 23 has been linked to the appropriate motions. (fms)
October 20, 2014 Filing 23 ANSWERING BRIEF in Opposition Plaintiff Hartig Drug Company's Opposition to Defendants' Motions to Dismiss the Complaint (D.I. #14 , D.I. #17 , and D.I. #19 ) filed by Hartig Drug Company Inc..Reply Brief due date per Local Rules is 10/30/2014. (Attachments: #1 Exhibit A)(Athey, J.) Modified on 10/21/2014 (fms).
September 25, 2014 Opinion or Order SO ORDERED, re #22 Stipulation, filed by Hartig Drug Company Inc., Set Briefing Schedule: re #17 Joint MOTION to Dismiss for Failure to State a Claim / Defendants Kyorin Pharmaceutical Co. Ltd. and Senju Pharmaceutical Co. Ltd.'s Joint Motion to Dismiss, #14 MOTION to Dismiss for Lack of Jurisdiction Over the Subject Matter . (Answering Brief due 10/20/2014., Reply Brief due 11/13/2014.) See stipulation for further details. Signed by Judge Sue L. Robinson on 9/25/2014. (fms)
September 24, 2014 Filing 22 STIPULATION and Proposed Order Regarding Briefing on Motions to Dismiss re #19 Joinder, #15 Opening Brief in Support, #17 Joint MOTION to Dismiss for Failure to State a Claim / Defendants Kyorin Pharmaceutical Co. Ltd. and Senju Pharmaceutical Co. Ltd.'s Joint Motion to Dismiss by Hartig Drug Company Inc.. (Athey, J.)
September 22, 2014 Filing 21 REDACTED VERSION of #16 Declaration by Allergan Inc.. (Attachments: #1 Exhibit 1)(Murphy, Regina)
September 22, 2014 Opinion or Order SO ORDERED, re #20 MOTION for Pro Hac Vice Appearance of Attorney Derrick K. Takeuchi and William F. Sondericker filed by Senju Pharmaceutical Co. Ltd. Signed by Judge Sue L. Robinson on 9/22/2014. (fms)
September 22, 2014 Pro Hac Vice Attorney Sara R. Kusiak for Kyorin Pharmaceutical Co. Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (els)
September 19, 2014 Filing 20 MOTION for Pro Hac Vice Appearance of Attorney Derrick K. Takeuchi and William F. Sondericker - filed by Senju Pharmaceutical Co. Ltd.. (Attachments: #1 Certification of Derrick K. Takeuchi, #2 Certification of William F. Sondericker)(Brauerman, Stephen)
September 18, 2014 Filing 19 JOINDER by Allergan Inc., joining in #17 Motion to Dismiss for Failure to State a Claim, . (Murphy, Regina)
September 18, 2014 Filing 18 Joint OPENING BRIEF in Support re #17 Joint MOTION to Dismiss for Failure to State a Claim / Defendants Kyorin Pharmaceutical Co. Ltd. and Senju Pharmaceutical Co. Ltd.'s Joint Motion to Dismiss filed by Kyorin Pharmaceutical Co. Ltd., Senju Pharmaceutical Co. Ltd..Answering Brief/Response due date per Local Rules is 10/6/2014. (Attachments: #1 Exhibit A)(Schladweiler, Benjamin)
September 18, 2014 Filing 17 Joint MOTION to Dismiss for Failure to State a Claim / Defendants Kyorin Pharmaceutical Co. Ltd. and Senju Pharmaceutical Co. Ltd.'s Joint Motion to Dismiss - filed by Kyorin Pharmaceutical Co. Ltd., Senju Pharmaceutical Co. Ltd.. (Schladweiler, Benjamin)
September 18, 2014 Filing 16 [SEALED] DECLARATION re #15 Opening Brief in Support -- Declaration of Jonathan M. Kafer -- by Allergan Inc.. (Attachments: #1 Exhibit 1)(Murphy, Regina)
September 18, 2014 Filing 15 OPENING BRIEF in Support re #14 MOTION to Dismiss for Lack of Jurisdiction Over the Subject Matter filed by Allergan Inc..Answering Brief/Response due date per Local Rules is 10/6/2014. (Murphy, Regina)
September 18, 2014 Filing 14 MOTION to Dismiss for Lack of Jurisdiction Over the Subject Matter - filed by Allergan Inc.. (Murphy, Regina)
September 18, 2014 Opinion or Order SO ORDERED, re #13 MOTION for Pro Hac Vice Appearance of Attorney John M. Majoras, Kevin. D. McDonald, Rosanna K. McCalips and Sara R. Kusiak filed by Kyorin Pharmaceutical Co. Ltd. Signed by Judge Sue L. Robinson on 9/18/2014. (fms)
September 18, 2014 Pro Hac Vice Attorney Rosanna K. McCalips for Kyorin Pharmaceutical Co. Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (dmp, )
September 17, 2014 Filing 13 MOTION for Pro Hac Vice Appearance of Attorney John M. Majoras, Kevin. D. McDonald, Rosanna K. McCalips and Sara R. Kusiak - filed by Kyorin Pharmaceutical Co. Ltd.. (Schladweiler, Benjamin)
September 17, 2014 Filing 12 NOTICE of Appearance by Benjamin J. Schladweiler on behalf of Kyorin Pharmaceutical Co. Ltd. (Schladweiler, Benjamin)
July 7, 2014 Filing 11 NOTICE of Change of Address by Brent W. Landau (Attachments: #1 Certificate of Service)(Athey, J.) Modified on 7/7/2014 (fms).
July 1, 2014 Opinion or Order SO ORDERED, re #10 MOTION for Pro Hac Vice Appearance of Attorney M. Sean Royall, Ashley E. Johnson and Jason C. McKenney of Gibson, Dunn & Crutcher LLP filed by Allergan Inc. Signed by Judge Sue L. Robinson on 7/1/2014. (fms)
July 1, 2014 Pro Hac Vice Attorney M. Sean Royall,Ashley E. Johnson,Jason C. McKenney for Allergan Inc. added for electronic noticing. (dmp, )
June 30, 2014 Filing 10 MOTION for Pro Hac Vice Appearance of Attorney M. Sean Royall, Ashley E. Johnson and Jason C. McKenney of Gibson, Dunn & Crutcher LLP - filed by Allergan Inc.. (Murphy, Regina)
June 25, 2014 Filing 9 CERTIFICATE OF SERVICE of Stipulation and Order by Hartig Drug Company Inc. re #6 Stipulation (Athey, J.)
June 25, 2014 Filing 8 WAIVER OF SERVICE returned executed by Hartig Drug Company Inc.: For Senju Pharmaceutical Co. Ltd. waiver sent on 6/20/2014, answer due 9/18/2014. (Athey, J.)
June 25, 2014 Filing 7 WAIVER OF SERVICE returned executed by Hartig Drug Company Inc.: For Kyorin Pharmaceutical Co. Ltd. waiver sent on 6/20/2014, answer due 9/18/2014. (Athey, J.)
June 25, 2014 Opinion or Order SO ORDERED, re #6 Stipulation filed by Hartig Drug Company Inc., Set/Reset Answer Deadlines: Allergan Inc. answer due 9/18/2014; Kyorin Pharmaceutical Co. Ltd. answer due 9/18/2014; Senju Pharmaceutical Co. Ltd. answer due 9/18/2014. Signed by Judge Sue L. Robinson on 6/25/2014. (fms)
June 24, 2014 Opinion or Order Filing 6 STIPULATION AND ORDER to answer, move or otherwise respond to the Complaint by Hartig Drug Company Inc.. (Athey, J.)
June 16, 2014 Pro Hac Vice Attorney Marvin L. Frank for Hartig Drug Company Inc. added for electronic noticing. (els)
June 16, 2014 Pro Hac Vice Attorney Melinda R. Coolidge for Hartig Drug Company Inc. added for electronic noticing. (els)
June 16, 2014 Pro Hac Vice Attorney Gregory A. Frank for Hartig Drug Company Inc. added for electronic noticing. (els)
June 16, 2014 Pro Hac Vice Attorney Brent W. Landau for Hartig Drug Company Inc. added for electronic noticing. (els)
June 13, 2014 Opinion or Order SO ORDERED, re #4 MOTION for Pro Hac Vice Appearance of Attorney Brent W. Landau, Melinda R. Coolidge, Gregory Frank, Marvin Frank filed by Hartig Drug Company Inc. Signed by Judge Sue L. Robinson on 6/13/2014. (fms)
June 11, 2014 Filing 5 SUMMONS Returned Executed by Hartig Drug Company Inc.. Allergan Inc. served on 6/9/2014, answer due 6/30/2014. (Athey, J.)
June 11, 2014 Case Assigned to Judge Sue L. Robinson. Please include the initials of the Judge (SLR) after the case number on all documents filed. (bkb)
June 10, 2014 Filing 4 MOTION for Pro Hac Vice Appearance of Attorney Brent W. Landau, Melinda R. Coolidge, Gregory Frank, Marvin Frank - filed by Hartig Drug Company Inc.. (Attachments: #1 Certification of Brent W. Landau, #2 Certification of Gregory Frank, #3 Certification of Marvin Frank, #4 Certification of Melinda Coolidge)(Athey, J.)
June 10, 2014 Filing 3 Disclosure Statement pursuant to Rule 7.1: identifying filed by Hartig Drug Company Inc.. (Athey, J.)
June 9, 2014 Summons Issued with Magistrate Consent Notice attached as to Allergan Inc. on 6/9/2014; Kyorin Pharmaceutical Co. Ltd. on 6/9/2014; Senju Pharmaceutical Co. Ltd. on 6/9/2014. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (els)
June 6, 2014 Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (els)
June 6, 2014 Filing 1 COMPLAINT filed with Jury Demand against Allergan Inc., Kyorin Pharmaceutical Co. Ltd., Senju Pharmaceutical Co. Ltd. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-1528914.) - filed by Hartig Drug Company Inc.. (Attachments: #1 Civil Cover Sheet)(els)

Access additional case information on PACER

Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.

Access this case on the Delaware District Court's Electronic Court Filings (ECF) System

Search for this case: Hartig Drug Company Inc. v. Senju Pharmaceutical Co. Ltd. et al
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Web [ Unicourt | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Allergan Inc.
Represented By: Regina S.E. Murphy
Represented By: Jack B. Blumenfeld
Represented By: Jason C. McKenney
Represented By: Ashley E. Johnson
Represented By: M. Sean Royall
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Kyorin Pharmaceutical Co. Ltd.
Represented By: Kevin D. McDonald
Represented By: Rosanna K. McCalips
Represented By: John M. Majoras
Represented By: Sara R. Kusiak
Represented By: David Evan Ross
Represented By: Benjamin J. Schladweiler
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Senju Pharmaceutical Co. Ltd.
Represented By: Derrick Takeuchi
Represented By: William F. Sondericker
Represented By: Stephen B. Brauerman
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: Hartig Drug Company Inc.
Represented By: Melinda R. Coolidge
Represented By: Eric Joseph Juray
Represented By: Gregory A. Frank
Represented By: Brent Landau
Represented By: J. Clayton Athey
Represented By: Marvin L. Frank
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?